Posted by: Sandra Moran in: ● January 27, 2012
Next up in my Q&A series on EA, I am going to address how the EA market is changing and what vendors are doing to support user’s new expectations. Question: What are some of the ways that EA is evolving and what changes are EA tool vendors implementing to support those changes?
Posted by: Sandra Moran in: ● January 25, 2012
Today I’m continuing my Q&A series on frequent questions asked about enterprise architecture and business process analysis tools. Over the past few months there has been a lot of chatter around the future of EA and BPA. Here’s another installment on the future of this market and the best way to leverage these tools to [...]
Posted by: Sandra Moran in: ● January 5, 2012
Cliché as it may be, I can’t stop myself from turning the page on the calendar of a new year and turning my mind to my personal goals for the year. Naturally, many organizations have a tendency to follow suit. Bolstered by this spirit of the possible, organizations begin to envision themselves achieving their goals [...]
Posted by: Peter Near in: ● December 18, 2011
We’re excited to announce that our customers can now leverage the capabilities of the OpenText enterprise content management (ECM) and dynamic case management (DCM) together to achieve better business outcomes by bridging the gap between content and process. Bringing Together Content and Process
Posted by: Sandra Moran in: ● November 30, 2011
In my blog post last month I covered a few of the lessons learned by early BPM adopters on how to begin a business process management (BPM) initiative. Based on many early BPM successes, we have seen the focus of BPM projects shift from just streamlining and improving a few key processes within their organization [...]
Posted by: Process Matters Blogger in: ● July 19, 2011
Regulatory Document Submission is one of the most time consuming, yet critical steps pharmaceutical, biotechnology and medical device companies must take to meet government requirements, ensure patient safety, and get a new product introduced to the market. While it is essential to the health of a pharmaceutical company to get its submissions issued efficiently, many [...]
